Fresenius Kabi Recalls KABIVEN IV Bags Due to Amino Acid Labeling Error
Fresenius Kabi is recalling 5,488 bags of KABIVEN IV solution because the label lists 3.1% amino acids, but the product actually contains 3.3%.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a minor labeling error regarding the concentration of an ingredient, with no reported illnesses or injuries in the source text.
Plain-English summary
Fresenius Kabi USA, LLC is recalling 5,488 bags of KABIVEN (Dextrose, Soybean Oil, Electrolytes, and Amino Acids) Injectable Emulsion. The recall was initiated due to a labeling error regarding the declared strength of the amino acids. The product is labeled as containing 3.1% amino acids, but it actually contains 3.3% amino acids.
The affected product is a prescription-only intravenous solution manufactured by Fresenius Kabi Uppsala, Sweden, and packaged in 1,540 mL and 2,053 mL bags. The specific lots involved are #10HH8781 and #10HH8739, both with an expiration date of 07-2016. The product was distributed nationwide in the United States, including Puerto Rico.
This recall is classified as FDA Class II. Healthcare providers and patients should check their inventory for the specific lot numbers and NDC codes listed in the recall notice. If the product has been administered, no specific adverse health consequences are reported in the source text, but the discrepancy in amino acid concentration should be noted for clinical records.
The recalled product
- Product
- KABIVEN (DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE)
- Brand
- KABIVEN
- Manufacturer
- Fresenius Kabi USA, LLC
- Category
- Drug — Intravenous Solution
- Hazard
- Affected units
- 5,488
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- 1) Lot # 10HH8781
- Expiry: 07-2016
- 2) Lot # 10HH8739
- Expiry: 07-2016.
UPCs (4)
- 0363323712105
- 0363323712204
- 0363323712150
- 0363323712259
Distribution
Related recalls
Same manufacturer · Fresenius Kabi USA, LLC
See all →- SevereFresenius Kabi Recalls Tyenne Injection Due to Glass Particles
FDA (Drugs) · 2026-09-02
- CriticalFresenius Kabi Recalls Morphine Syringes Due to Labeling Error
FDA (Drugs) · 2026-08-26
- HighXylocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateGlycopyrrolate Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateFDA Recalls Xylocaine Injections Due to Hair Contamination
FDA (Drugs) · 2026-07-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02